External quality assessment of laboratory performance – European Antimicrobial Resistance Surveillance Network (EARS-Net), 2018
This report provides an analysis of the external quality assessment (EQA) performance with antimicrobial susceptibility testing (AST) of laboratories participating in the European Antimicrobial Resistance Surveillance Network in 2018. A total of 860 laboratories (1 – 114 per country) from 30 EU/EEA countries participated in the EQA exercise. Six bacterial strains were used: Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, Enterococcus faecium and Streptococcus pneumoniae.
Euro-GASP external quality assessment scheme for Neisseria gonorrhoeae antimicrobial susceptibility testing
External quality assessment (EQA) is an essential part of any laboratory-based surveillance system, allowing for the monitoring of performance and comparability of results from participating laboratories, identification of potential issues, and deployment of resources and training where necessary.
Developing a reporting system for the surveillance of HIV drug resistance in Europe
A pilot project was carried out to investigate the feasibility of HIVDR surveillance in EU/EEA countries and to make recommendations for the design and implementation of a potential future HIVDR surveillance system at the European level.
The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2017
The data on antimicrobial resistance in zoonotic and indicator bacteria in 2017, submitted by 28 EU Member States (MSs), were jointly analysed by EFSA and ECDC. Resistance in zoonotic Salmonella and Campylobacter from humans, animals and food, and resistance in indicator Escherichia coli as well as meticillin-resistant Staphylococcus aureus in animals and food were addressed, and temporal trends assessed.
Ten years of external quality assessment (EQA) of Neisseria gonorrhoeae antimicrobial susceptibility testing in Europe elucidate high reliability of data
Cole, M.J., Quaye, N., Jacobsson, S., Day, M., Fagan, E., Ison, C., Pitt, R., Seaton, S., Woodford, N., Stary, A., Pleininger, S., Crucitti, T., Hunjak, B., Maikanti, P., Hoffmann, S., Viktorova, J., Buder, S., Kohl, P., Tzelepi, E., Siatravani, E., Balla, E., Hauksdóttir, G.S., Rose, L., Stefanelli, P., Carannante, A., Pakarna, G., Mifsud, F., Cassar, R.Z., Linde, I., Bergheim, T., Steinbakk, M., Mlynarczyk-Bonikowska, B., Borrego, M.-J., Shepherd, J., Pavlik, P., Jeverica, S., Vazquez, J., Abad, R., Weiss, S., Spiteri, G., Unemo, M.
Advancing biological hazards risk assessment
Messens, W., Hugas, M., Afonso, A., Aguilera, J., Berendonk, T.U., Carattoli, A., Dhollander, S., Gerner-Smidt, P., Kriz, N., Liebana, E., Medlock, J., Robinson, T., Stella, P., Waltner-Toews, D., Catchpole, M.
Strong correlation between the rates of intrinsically antibiotic-resistant species and the rates of acquired resistance in Gram-negative species causing bacteraemia, EU/EEA, 2016
Jarlier, V., Diaz Högberg, L., Heuer, O.E., Campos, J., Eckmanns, T., Giske, C.G., Grundmann, H., Johnson, A.P., Kahlmeter, G., Monen, J., Pantosti, A., Rossolini, G.M., van de Sande-Bruinsma, N., Vatopoulos, A., Żabicka, D., Žemličková, H., Monnet, D.L., Simonsen, G.S., Ears-Net Participants
Targets for the reduction of antibiotic use in humans in the Transatlantic Taskforce on Antimicrobial Resistance (TATFAR) partner countries
D'Atri, F., Arthur, J., Blix, H.S., Hicks, L.A., Plachouras, D., Monnet, D.L., The European Survey On Transatlantic Task Force On Antimicrobial Resistance Tatfar Action Group
Investing in public health microbiology laboratories in western balkan countries enhances health security from communicable disease threats in Europe
Bajoriniene, A., Leitmeyer, K.C., Struelens, M.J., Kokki, M.H.